CNIPA.AI
返回搜索
档案

ALGORITHMS DRIVING SYSTEMS WHICH TITRATE MEAL DOSES BASED ON POST-PRANDIAL GLUCOSE EXCURSIONS WITHOUT TARGET ADAPTATIONS

发明专利审中
11浏览
33权利要求 · 2 独立
§ Ⅰ

卷宗概要

发明人

Michael J. Rosinko; Mike Mensigner; Haripriyan Hamapuran; Sean Saint

IPC 分类

G16H 20/60G16H 20/17

CPC 分类

G16H20/60G16H20/17

Novel enhanced methods for adapting meal boluses using post-prandial glucose values enable systems that titrate meal doses based on post-prandial glucose excursions where the pattern of the glucose excursion may be evaluated in the post-prandial period to include the minimum and/or maximum excursion, the area under the curve (glucose relative to target glucose) or difference between the glucose and an expected glucose response based on estimated carbs consumed and the glucose response of the insulin delivered. Additionally, in a bihormonal implementation, the meal dose may be further adapted based on the amount of glucagon delivered for example reducing the meal size if glucagon is delivered. Apps are disclosed, taking, for example, blousing meal announcements differently to drive control parameters than previously disclosed among prior art systems, including without adaptation of glucose targets comprised of Algo Two Point Zero et seq.

原文(中文)

Novel enhanced methods for adapting meal boluses using post-prandial glucose values enable systems that titrate meal doses based on post-prandial glucose excursions where the pattern of the glucose excursion may be evaluated in the post-prandial period to include the minimum and/or maximum excursion, the area under the curve (glucose relative to target glucose) or difference between the glucose and an expected glucose response based on estimated carbs consumed and the glucose response of the insulin delivered. Additionally, in a bihormonal implementation, the meal dose may be further adapted based on the amount of glucagon delivered for example reducing the meal size if glucagon is delivered. Apps are disclosed, taking, for example, blousing meal announcements differently to drive control parameters than previously disclosed among prior art systems, including without adaptation of glucose targets comprised of Algo Two Point Zero et seq.